Navigation

Antisocial personality disorders (ASPD)

Antisocial personality disorder: treatment, management and prevention

Status: History
Publication date: January 2009
Wave: 12
Process: CG
Topic area:
 

NICE project team

Centre for clinical practice lead: Andrew Dillon
Communications manager: Sarita Tamber
Guidelines commissioning manager: Claire Turner
Guidelines coordinator: Bobbie Lloyd
Patient involvement lead: Victoria Thomas
Guidelines Development Group: The Guideline Development Group (GDG) oversees the development process.
Top


Email enquiries

If you have any queries please email nice@nice.org.uk
Top


 

Provisional schedule

Scoping workshop: 01 December 2006
Consultation on draft scope with stakeholders: 21 November - 19 December 2006
Consultation on draft guideline with stakeholders: 8 August - 2 October 2008
Pre-publication check: TBC
Publication date: January 2009
Top


 

Project history

Date Update
12 August 2006 The first draft of the scope is currently in preparation. The scope will define what aspects of care the guideline will cover and to whom it will apply.
21 November 2006 The draft scope is out for consultation with stakeholders. The scope defines what aspects of care the guideline will cover and to whom it will apply. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed above, by the deadline shown.
23 January 2008 NCC contact changed from Catherine Pettinari to Ryan Li.
 

The scope defines what aspects of care are covered by the guideline and to whom it applies.

Comments that were made by stakeholders during the consultation on the scope can be seen in the scope consultation table.

The Guideline Development Group (GDG) oversees the development process.

The NCCs may make a focussed call for evidence on specific clinical questions or subquestions, after it has done initial searches. It will be able to make a call at any point during development of the guideline, and stakeholders will usually be given 4 weeks to respond. The NCC will approach all registered stakeholders for this evidence. The NCC may not issue any calls for evidence for a guideline if the Guideline Development Group (GDG) feels it is not necessary. In addition, the NCCs will accept relevant confidential data for consideration by the GDG.

Development of the clinical guideline is under way and is being led by the National Collaborating Centre. The Guideline Development Group meets regularly to oversee and assist the identification, review and synthesis of the evidence, the incorporation of expert consensus opinion and the translation of the evidence into recommendations for practice and audit criteria. Three versions of the guideline are under preparation: a full guideline, a NICE short-form guideline and information for the public. Please see timescales above for dates of the first and final rounds of consultation with stakeholders.

8 August 2008 The consultation draft of the guideline is out for consultation with stakeholders. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed below, by the deadline shown.
3 October 2008 Consultation on the draft of the guideline is complete and the guideline is being modified in the light of comments received.
Top


 

Key documents

This page was last updated: 07 October 2011

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.